Related Experiment Video
Updated: Jul 28, 2026

13:42
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017
Self testing, an emerging component of clinical chemistry
Clinical Chemistry
|June 1, 1984
Summary
Self-testing in healthcare has grown significantly due to its medical relevance, cost-effectiveness, and convenience. Clinical chemists, physicians, and industry play vital roles in advancing and utilizing these important health delivery procedures.
Area of Science:
- Clinical Chemistry
- Health Delivery Systems
- Diagnostic Procedures
Background:
- Self-testing has evolved over 70 years, with a surge in interest and application in the last two decades.
- The practice is underpinned by medical relevance, cost containment, and user convenience.
- Anticipated growth in self-testing is linked to increasing medical needs and procedural advancements.
Observation:
- Clinical chemists are crucial for developing, evaluating, and ensuring the quality of self-testing procedures.
- Physicians maintain a central role in diagnosis and therapy, interpreting self-testing results and guiding patient care.
- Industry is pivotal in supplying reagents, instruments, and funding for new self-testing products, alongside customer service.
Findings:
- The collaborative efforts of clinical chemists, physicians, and industry have established self-testing as a key component of clinical laboratory practice.
- Quality assurance and proficiency programs for self-testing users are effectively managed by clinical chemists.
- Physicians require familiarity with self-testing to interpret results and integrate them into patient management.
Implications:
- Continued innovation in self-testing procedures by clinical chemists will expand healthcare options.
- The physician's role in interpreting self-testing results is essential for accurate diagnosis and treatment.
- Industry's commitment to high-quality products and service will drive the future adoption and success of self-testing.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

